12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers Hillstream BioPharma (NASDAQ:HILS) stock rose 95.2% to $1.31 during Tuesday’s regular session. As of 12:30 EST, Hillstream…
Palisade Bio Announces Closing of $2.5M Registered Direct Offering, Concurrent Private Placement Priced Above Market Under Nasdaq Rules
Palisade Bio, Inc. (NASDAQ:PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, is announcing today that it has closed its previously
Why Horizon Global Shares Are Trading Higher By Over 340%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Horizon Global Corporation (NYSE: HZN) shares surged 341% to $1.7161 after the company announced it will be acquired by First Brands Group.
Wall Street Starts 2023 On Positive Note
U.S. stocks traded higher this morning, with the Dow Jones gaining around 200 points on Tuesday.
12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers Novo Integrated Sciences (NASDAQ:NVOS) stock rose 44.2% to $0.29 during Monday’s after-market session. At the close, Novo…
Dow Falls 300 Points On Last Trading Session of 2022; S&P 500 Down 1%
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 300 points on Friday.
Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday’s Mid-Day Session
Gainers
Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the contemplated public offering.
US Stocks Open Lower; Dow Drops 250 Points
U.S. stocks traded lower this morning, with the Dow Jones dropping around 250 points on Friday.
Palisade Bio Announces $2.5M Registered Direct Offering And Concurrent Private Placement Priced Above Market Under Nasdaq Rules
Palisade Bio, Inc. (NASDAQ:PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, is announcing today that it has entered into definitive
Why Dermata Therapeutics Shares Are Trading Higher By Over 100%; Here Are 21 Stocks Moving Premarket
Gainers
Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares rose 105% to $0.41 in pre-market trading after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the contemplated public offering.